Clinical Trial Update: INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

View source ↗

Summary

Clinical trial update for INGEVITY+ Active Fixation Pace/Sense Lead study (NCT04346537) completed with results posted in May 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia

Drugs mentioned

• INGEVITY+ Active Fixation Pace/Sense Lead (null)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Bradycardia | Status: COMPLETED | Results posted: 2022-05-12